Skip to main content
SpringerLink
Log in

A post-marketing surveillance study* has revealed no new evidence to suggest that the new measles mumps and rubella virus (MMR) vaccine [Priorix]

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Miller E, Andrews N, Stowe J, Grant A, Waight P, Taylor B.Risks of convulsion and aseptic meningitis following measles-mumps-rubella vaccination in the United Kingdom. American Journal of Epidemiology 165: 704-709, No. 6, 15 Mar 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

A post-marketing surveillance study* has revealed no new evidence to suggest that the new measles mumps and rubella virus (MMR) vaccine [Priorix]. React. Wkly. 1150, 3 (2007). https://doi.org/10.1007/BF03272442

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03272442

Keywords

Search

Navigation